Oncology and Hematology
113-128 of 789
Alessandra Tedeschi, MD
Chan Y. Cheah, MBBS
Nicolas Girard, MD
Louise Lim, MD
Jacob Sands, MD
Stephanie McDonald, MSN, FNP-BC, AOCNP
Irene Su, MD, MSCE
Steve Jackson, PharmD
Lyudmila A. Bazhenova, MD
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
Aditya Bardia, MD, MPH, FASCO
Steve Jackson, PharmD
Alexander Spira, MD, PhD, FACP
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
Alexandria May, PharmD, BCPS
Lowell B. Anthony, MD, FACP
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
- Oncology and Hematology
DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
Sara A. Hurvitz, MD, FACP
Brian P. McDonough, MD, FAAFP
Andrew E. Hendifar, MD
- Oncology and Hematology
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD
